These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10211483)

  • 1. Lipoprotein-free amyloidogenic peptides in plasma are elevated in patients with sporadic Alzheimer's disease and Down's syndrome.
    Matsubara E; Ghiso J; Frangione B; Amari M; Tomidokoro Y; Ikeda Y; Harigaya Y; Okamoto K; Shoji M
    Ann Neurol; 1999 Apr; 45(4):537-41. PubMed ID: 10211483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble Abeta homeostasis in AD and DS: impairment of anti-amyloidogenic protection by lipoproteins.
    Matsubara E; Sekijima Y; Tokuda T; Urakami K; Amari M; Shizuka-Ikeda M; Tomidokoro Y; Ikeda M; Kawarabayashi T; Harigaya Y; Ikeda S; Murakami T; Abe K; Otomo E; Hirai S; Frangione B; Ghiso J; Shoji M
    Neurobiol Aging; 2004 Aug; 25(7):833-41. PubMed ID: 15212837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heritability of plasma amyloid beta in typical late-onset Alzheimer's disease pedigrees.
    Ertekin-Taner N; Graff-Radford N; Younkin LH; Eckman C; Adamson J; Schaid DJ; Blangero J; Hutton M; Younkin SG
    Genet Epidemiol; 2001 Jul; 21(1):19-30. PubMed ID: 11443731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alzheimer's disease: beta amyloid and lipid metabolism].
    Kudinova NV; Kudinov AR; Berezov TT
    Vopr Med Khim; 1998; 44(1):28-34. PubMed ID: 9575610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
    N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frame-shifted amyloid precursor protein found in Alzheimer's disease and Down's syndrome increases levels of secreted amyloid beta40.
    van Dijk R; Fischer DF; Sluijs JA; Sonnemans MA; Hobo B; Mercken L; Mann DM; Hol EM; van Leeuwen FW
    J Neurochem; 2004 Aug; 90(3):712-23. PubMed ID: 15255950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid beta concentrations in older people with Down syndrome and dementia.
    Jones EL; Hanney M; Francis PT; Ballard CG
    Neurosci Lett; 2009 Feb; 451(2):162-4. PubMed ID: 19111900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and mild cognitive impairment.
    Pesaresi M; Lovati C; Bertora P; Mailland E; Galimberti D; Scarpini E; Quadri P; Forloni G; Mariani C
    Neurobiol Aging; 2006 Jun; 27(6):904-5. PubMed ID: 16638622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lipoprotein beta-amyloid in subjects with Alzheimer's disease or mild cognitive impairment.
    Mamo JC; Jian L; James AP; Flicker L; Esselmann H; Wiltfang J
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):395-403. PubMed ID: 18583625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased soluble APPalpha, Abeta 1-42, and anti-Abeta 1-42 antibodies in plasma from down syndrome patients.
    Conti E; Galimberti G; Piazza F; Raggi ME; Ferrarese C
    Alzheimer Dis Assoc Disord; 2010; 24(1):96-100. PubMed ID: 19571731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma.
    Koudinov A; Matsubara E; Frangione B; Ghiso J
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1164-71. PubMed ID: 7802646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that Abeta42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype.
    De Jonghe C; Cras P; Vanderstichele H; Cruts M; Vanderhoeven I; Smouts I; Vanmechelen E; Martin JJ; Hendriks L; Van Broeckhoven C
    Neurobiol Dis; 1999 Aug; 6(4):280-7. PubMed ID: 10448055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma biomarkers of Alzheimer's disease.
    Kawarabayashi T; Shoji M
    Curr Opin Psychiatry; 2008 May; 21(3):260-7. PubMed ID: 18382225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum neopterin levels in adults with Down syndrome.
    Mehta PD; Patrick BA; Dalton AJ; Patel B; Mehta SP; Pirttila T; Coyle PK
    J Neuroimmunol; 2005 Jul; 164(1-2):129-33. PubMed ID: 15908015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain.
    Russo C; Salis S; Dolcini V; Venezia V; Song XH; Teller JK; Schettini G
    Neurobiol Dis; 2001 Feb; 8(1):173-80. PubMed ID: 11162251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma amyloid beta protein 1-42 levels in fetuses with Down syndrome.
    Bartha JL; Soothill PW
    Early Hum Dev; 2005 Apr; 81(4):351-4. PubMed ID: 15814219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees.
    Ertekin-Taner N; Graff-Radford N; Younkin LH; Eckman C; Baker M; Adamson J; Ronald J; Blangero J; Hutton M; Younkin SG
    Science; 2000 Dec; 290(5500):2303-4. PubMed ID: 11125143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of amyloid beta proteins Abeta1-40 and Abeta1-42(43) are elevated in Down's syndrome.
    Tokuda T; Fukushima T; Ikeda S; Sekijima Y; Shoji S; Yanagisawa N; Tamaoka A
    Ann Neurol; 1997 Feb; 41(2):271-3. PubMed ID: 9029078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased amyloid beta protein levels in children and adolescents with Down syndrome.
    Mehta PD; Capone G; Jewell A; Freedland RL
    J Neurol Sci; 2007 Mar; 254(1-2):22-7. PubMed ID: 17275850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.